ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 76751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 76751; 2) Community: the network communities that were significantly associated with the response to NSC 76751; 3) Molecule: the relationships between components within communities and NSC 76751; 4) MDR: the compounds that were significantly associated with the NSC 76751.

NSC Compound Enrichment Correlation
NSC 697646 Null 0.00850121609156378 0.10545268
NSC 713048 Null 0.00850121609156378 -0.072477871
NSC 727680 MMP-9/MMP-13 Inhibitor l CalBioChem Cat. No. 444252 0.0112341554440421 0.21980572
NSC 760951 Null 0.0112341554440421 0.25682616
NSC 127753 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(p-phenethylphenyl)-, monohydrochloride 0.0121445142278023 -0.16645973
NSC 128887 Benzenebutanamide, N-(phenylmethyl)-4-bis(2-chloro- ethyl)amino]- 0.0121445142278023 0.24223151
NSC 188491 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0121445142278023 0.075333508
NSC 268251 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE 0.0121445142278023 -0.054254642
NSC 304421 LEUROSINE-N-OXIDE 0.0121445142278023 -0.05154456
NSC 382028 Maxima isoflavone D 0.0121445142278023 -0.031016204
Total:17  Current:2    [First] [Prev] [Next] [Last]